Klinische Studie

VIATORR Device Registry

NCT: NCT05661331 · ACTIVE_NOT_RECRUITING

NCT-IDNCT05661331

Medizinische Daten: StatusACTIVE_NOT_RECRUITING

Startdatum2023-02-21

Abschluss2028-12-31

SponsorW.L.Gore & Associates (INDUSTRY)

First posted2022-12-22

Last updated2026-10-07

Kurzzusammenfassung

The primary objective is to confirm the clinical performance and safety of the GORE® VIATORR® TIPS (Transjugular Intrahepatic Portosystemic Shunt) Endoprosthesis with Controlled Expansion throughout the device functional lifetime of 3 years in real world setting. The secondary objective is to collect information on quality of life after treatment with the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion. Additionally, data will be collected on the safety and performance of the GORE TIPS Set when utilized.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.